2-Amino-6-chloropyridine-3,5-dicarbonitrile

Catalog No. :
ACSTRK134
CAS No. :
51768-01-5
Molecular Formula :
C7H3ClN4
Molecular Weight :
178.58

IUPAC Name:2-amino-6-chloropyridine-3,5-dicarbonitrile

2-Amino-6-chloropyridine-3,5-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$395.00Login to see priceInquiryInquiry
100mg95%$585.00Login to see priceInquiryInquiry
250mg95%$827.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-6-chloropyridine-3,5-dicarbonitrile
IUPAC Name2-amino-6-chloropyridine-3,5-dicarbonitrile
MDL No.MFCD00204019
Molecular FormulaC7H3ClN4
Molecular Weight178.58
SMILESN#CC1=CC(C#N)=C(Cl)N=C1N
InChI KeyOKTHXARAGRKGBQ-UHFFFAOYSA-N
Synonym2-AMINO-6-CHLORO-3,5-DICYANOPYRIDINE;2-Amino-6-chloro-3,5-dicyanopyridine ,97%;2-aMino-6-chloropyridine-3,5-dicarbonitrile;3,5-Pyridinedicarbonitrile, 2-amino-6-chloro-;2-AMINO-6-CHLORO-3,5-DICYANOPYRIDINE ISO 9001:2015 REACH;2-Amino-6-chloro-35-pyridinedicarbonitrile
CAS No.51768-01-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSTRK134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACSTRK134 route product structure diagram
    ACSTRK13451768-01-5
Inquiry

2. ACSTRK134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSTRK134 route product structure diagram
    ACSTRK13451768-01-5
Inquiry

Comments (0)